Prophylaxis of Fungal Invasive Infections in Leukemia
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
- To assess the overall clinical yield - in terms of efficacy and safety endpoints of
adding caspofungin as prophylaxis of Invasive Pulmonary Aspergillosis in patients
undergoing induction treatment for newly diagnosed acute leukemia
- To investigate the prognostic significance of Ptx3 at diagnosis and during the first
chemotherapy cycle with respect to the development of IPA